General Motors, poised at a transformative point in the automotive sector, offers investors a potential 35% upside with a target price of $60. This is driven by an expanding North...
Ligand Pharmaceuticals, a low-risk player in the biotech space, shows promise with a 12-month target of $165, reflecting 15% upside. The firm's clever asset-light model yields high-margin revenues through royalties...
Key Takeaways Geopolitical tensions, notably the significant use of THAAD interceptors in the June 2025 Israel-Iran conflict, have exposed stockpile vulnerabilities and are driving urgent global demand for Lockheed Martin’s...
Key Takeaways Trump Media & Technology Group’s (DJT) stock performance is highly sensitive to political news cycles, frequently diverging from broader market indices like the Nasdaq Composite during periods of...
Key Takeaways Sarepta’s gene therapy, Elevidys, faces a critical juncture as the FDA considers lifting a distribution hold for ambulatory Duchenne muscular dystrophy patients, potentially reviving its commercial trajectory. The...
Key Takeaways Analysts forecast UnitedHealth Group’s Q2 2025 earnings per share at approximately $4.63 on revenues of $111.6 billion, indicating margin compression despite strong top-line growth. The medical loss ratio...
Key Takeaways Major banks, led by JPMorgan Chase, are beginning to charge fintech intermediaries for customer data access, citing the significant strain high-volume data requests place on their legacy infrastructure....
Key Takeaways AI agents are demonstrably outperforming junior human analysts in core financial tasks, achieving higher accuracy (92% vs 85% in one study) and completing complex modelling work in minutes...
Key Takeaways Multiple analysts have upgraded AMD, with UBS raising its price target to $210, citing strong potential in AI and data centre markets. The company’s data centre revenue surged...
Key Takeaways Financial institutions, including JPMorgan Chase and Deutsche Bank, have incurred over 650 million USD in settlements related to facilitating Jeffrey Epstein’s activities, with further litigation pending. Ongoing appeals...
